Unit of Reproductive Medicine, Clínica Las Condes, Santiago, Chile.
Program of Ethics and Public Policies in Human Reproduction, Facultad de Medicina, Universidad Diego Portales, Santiago, Chile.
JBRA Assist Reprod. 2022 Nov 9;26(4):637-658. doi: 10.5935/1518-0557.20220034.
What was the utilization, effectiveness and safety of assisted reproductive technology (ART) in Latin America during 2019?
This was a retrospective collection of multinational data on ART performed at 196 institutions from 15 countries.
A total of 106,918 initiated cycles, 18,133 deliveries and 21,096 births were reported. ART utilization was 24-558 cycles per million inhabitants. Women aged ≥40 years represented 32.9% of fresh IVF and intracytoplasmic sperm injection (ICSI) cycles. After removing freeze-all cycles, the delivery rate per oocyte retrieval was 17.3% for ICSI and 19.5% for IVF. Overall, single-embryo transfer (SET) represented 36.2% of fresh transfers, with a 19.5% delivery rate per transfer, increasing to 30.7% for elective SET and 32.7% for blastocyst elective SET (eSET). The delivery rate for double-embryo transfers (DET) was 27.8%, increasing to 37.1% after elective DET. This 6.4% increment in deliveries between eSET and elective DET resulted in a 12-fold increase in twin births. Furthermore, overall perinatal mortality was more than two-fold higher for twin compared with singleton deliveries. The delivery rate for frozen-thawed SET reached 28.1%, most being blastocyst transfers. Of all births, 72.3% were singletons, 26.4% twins and 1.3% triplets and higher multiples. Preterm deliveries reached 14.3% for singletons and 58.1% for twins. Perinatal mortality was 7.4‰ in singletons, 17.2‰ for twins and 62.9‰ for triplets or higher.
The number of initiated cycles has slowly increased in countries with laws or regulations facilitating access. FET cycles predominate and blastocyst SET are also increasing. The data show that, especially in young women and oocyte recipients, when there is more than one blastocyst for transfer, eSET should be the rule.
2019 年,拉丁美洲辅助生殖技术(ART)的应用、有效性和安全性如何?
这是一项对来自 15 个国家的 196 个机构进行的多国 ART 数据的回顾性收集。
共报告了 106918 个起始周期、18133 次分娩和 21096 次活产。ART 的使用率为每百万居民 24-558 个周期。年龄≥40 岁的妇女占新鲜体外受精(IVF)和胞浆内单精子注射(ICSI)周期的 32.9%。去除全冷冻周期后,ICSI 的每取卵周期活产率为 17.3%,IVF 为 19.5%。总体而言,新鲜胚胎移植(SET)中 36.2%为单胚胎移植,每移植活产率为 19.5%,选择性 SET 增加至 30.7%,囊胚选择性 SET(eSET)增加至 32.7%。双胚胎移植(DET)的活产率为 27.8%,选择性 DET 后增加至 37.1%。eSET 和选择性 DET 之间每增加 6.4%的分娩,双胞胎的出生率增加了 12 倍。此外,与单胎分娩相比,双胎围产期死亡率高出两倍以上。冷冻解冻 SET 的活产率达到 28.1%,大部分为囊胚转移。所有分娩中,72.3%为单胎,26.4%为双胞胎,1.3%为三胞胎及以上。早产分娩在单胎中达到 14.3%,在双胞胎中达到 58.1%。单胎围产期死亡率为 7.4‰,双胞胎为 17.2‰,三胞胎或以上为 62.9‰。
在法律或法规允许获取的国家,启动周期的数量呈缓慢上升趋势。FET 周期占主导地位,囊胚 SET 也在增加。数据显示,特别是在年轻妇女和卵子接受者中,当有多个囊胚用于移植时,应优先选择 eSET。